APT Medical Inc (688617) - Net Assets

Latest as of March 2026: CN¥3.01 Billion CNY ≈ $440.03 Million USD

Based on the latest financial reports, APT Medical Inc (688617) has net assets worth CN¥3.01 Billion CNY (≈ $440.03 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥3.43 Billion ≈ $501.99 Million USD) and total liabilities (CN¥423.40 Million ≈ $61.96 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 688617 tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CN¥3.01 Billion
% of Total Assets	87.66%
Annual Growth Rate	40.07%
5-Year Change	77.43%
10-Year Change	N/A
Growth Volatility	92.09

APT Medical Inc - Net Assets Trend (2017–2025)

This chart illustrates how APT Medical Inc's net assets have evolved over time, based on quarterly financial data. See how many days can APT Medical Inc fund operations to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for APT Medical Inc (2017–2025)

The table below shows the annual net assets of APT Medical Inc from 2017 to 2025. For live valuation and market cap data, see market value of APT Medical Inc.

Year	Net Assets	Change
2025-12-31	CN¥3.18 Billion ≈ $465.03 Million	+24.39%
2024-12-31	CN¥2.55 Billion ≈ $373.85 Million	+30.22%
2023-12-31	CN¥1.96 Billion ≈ $287.10 Million	+9.54%
2022-12-31	CN¥1.79 Billion ≈ $262.09 Million	+0.00%
2021-12-31	CN¥1.79 Billion ≈ $262.09 Million	+297.94%
2020-12-31	CN¥450.09 Million ≈ $65.86 Million	+30.12%
2019-12-31	CN¥345.90 Million ≈ $50.62 Million	+27.78%
2018-12-31	CN¥270.70 Million ≈ $39.61 Million	+26.24%
2017-12-31	CN¥214.43 Million ≈ $31.38 Million	--

Equity Component Analysis

This analysis shows how different components contribute to APT Medical Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 2191.4% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Retained Earnings	CN¥2.29 Billion	74.16%
Common Stock	CN¥141.03 Million	4.57%
Other Comprehensive Income	CN¥79.46 Million	2.57%
Other Components	CN¥577.77 Million	18.71%
Total Equity	CN¥3.09 Billion	100.00%

APT Medical Inc Competitors by Market Cap

The table below lists competitors of APT Medical Inc ranked by their market capitalization.

Company	Market Cap
Masan Group Corp VN:MSN	$3.96 Billion
Cosan SA ADR NYSE:CSAN	$3.96 Billion
Travere Therapeutics Inc NASDAQ:TVTX	$3.96 Billion
ExlService Holdings Inc NASDAQ:EXLS	$3.96 Billion
Caesars Entertainment Corporation NASDAQ:CZR	$3.95 Billion
Parq Arauco SN:PARAUCO	$3.95 Billion
Broadstone Net Lease Inc NYSE:BNL	$3.95 Billion
SOLV Energy, Inc. Class A Common Stock NASDAQ:MWH	$3.95 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in APT Medical Inc's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 2,516,339,545 to 3,088,667,057, a change of 572,327,512 (22.7%).
Net income of 820,636,583 contributed positively to equity growth.
Dividend payments of 170,189,064 reduced retained earnings.
Share repurchases of 99,942,513 reduced equity.
Other comprehensive income decreased equity by 8,102,447.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	CN¥820.64 Million	+26.57%
Dividends Paid	CN¥170.19 Million	-5.51%
Share Repurchases	CN¥99.94 Million	-3.24%
Other Comprehensive Income	CN¥-8.10 Million	-0.26%
Other Changes	CN¥29.92 Million	+0.97%
Total Change	CN¥-	22.74%

Book Value vs Market Value Analysis

This analysis compares APT Medical Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 8.75x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 94.06x to 8.75x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2017-12-31	CN¥2.04	CN¥191.64	x
2018-12-31	CN¥2.57	CN¥191.64	x
2019-12-31	CN¥3.32	CN¥191.64	x
2020-12-31	CN¥4.39	CN¥191.64	x
2021-12-31	CN¥12.89	CN¥191.64	x
2022-12-31	CN¥12.42	CN¥191.64	x
2023-12-31	CN¥13.45	CN¥191.64	x
2024-12-31	CN¥17.84	CN¥191.64	x
2025-12-31	CN¥21.90	CN¥191.64	x

Capital Efficiency Dashboard

This dashboard shows how efficiently APT Medical Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 26.57%
The company demonstrates strong efficiency in generating profits from shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 31.76%
• Asset Turnover: 0.71x
• Equity Multiplier: 1.18x
Recent ROE (26.57%) is above the historical average (20.56%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2017	16.10%	22.51%	0.61x	1.18x	CN¥13.06 Million
2018	7.97%	8.90%	0.74x	1.21x	CN¥-5.47 Million
2019	23.62%	20.44%	0.72x	1.60x	CN¥47.62 Million
2020	24.06%	23.11%	0.81x	1.28x	CN¥64.74 Million
2021	11.69%	25.09%	0.41x	1.13x	CN¥30.11 Million
2022	20.30%	29.44%	0.55x	1.26x	CN¥181.69 Million
2023	28.00%	32.35%	0.64x	1.35x	CN¥343.21 Million
2024	26.75%	32.59%	0.69x	1.18x	CN¥421.52 Million
2025	26.57%	31.76%	0.71x	1.18x	CN¥511.77 Million

Industry Comparison

This section compares APT Medical Inc's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

Industry: Medical Devices
Average net assets among peers: $3,442,122,104
Average return on equity (ROE) among peers: 12.05%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
APT Medical Inc (688617)	CN¥3.01 Billion	16.10%	0.14x	$3.96 Billion
Shanghai Kehua Bio-Engineering Co Ltd (002022)	$4.98 Billion	-4.70%	0.37x	$371.06 Million
Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223)	$2.13 Billion	17.09%	0.37x	$3.63 Billion
Double Medical Technology Inc (002901)	$3.11 Billion	2.98%	0.27x	$2.56 Billion
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932)	$6.77 Billion	62.15%	0.36x	$506.97 Million
Lepu Medical Tech Beijing (300003)	$10.54 Billion	17.10%	0.73x	$3.19 Billion
INKON Life Technology Co Ltd (300143)	$343.97 Million	0.00%	1.34x	$764.39 Million
Edan Instruments Inc (300206)	$1.25 Billion	3.50%	0.14x	$1.15 Billion
Guangdong Biolight Meditech Co Ltd (300246)	$1.39 Billion	-4.69%	0.82x	$735.30 Million
Beijing Leadman Biochemistry Co Ltd (300289)	$761.02 Million	12.92%	0.49x	$467.29 Million
Sinocare Inc (300298)	$3.14 Billion	14.20%	0.47x	$1.17 Billion

About APT Medical Inc

SHG:688617 China Medical Devices

Market Cap

$3.96 Billion

CN¥27.03 Billion CNY

Market Cap Rank

#4221 Global

#695 in China

Share Price

CN¥191.64

Change (1 day)

-2.42%

52-Week Range

CN¥191.64 - CN¥331.86

All Time High

CN¥453.00